Fig. 1From: Clinical trial considerations on male contraception and collection of pregnancy information from female partner: updateSafety margin estimations: small molecules. AUC area under the curve, C max maximum concentration, C plasma plasma concentration, C semen seminal concentration, EFD embryo-fetal development, MABEL minimum anticipated biological effect level, NOAEL no adverse effect levelBack to article page